lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
220 rows where filing_period = "third_quarter", filing_year = 2013 and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1420604 | CEPHEID ff817a32-76d4-42f1-a227-410d397a89d9 | Q3 | CEPHEID | 400270233 | CEPHEID | 2013 | third_quarter | MED | See page fiveLobbying Issues: Molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight, global health funding comparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE | 70000 | 0 | 0 | 2013-07-19T17:33:37.777000-04:00 | |
| 1437060 | COLBY & COMPANY 3ef432c3-6944-47f0-af9d-b907ecf75162 | Q3 | COLBY & COMPANY | 400394858 | BIOOHIO | 2013 | third_quarter | MED | Repeal of medical device tax. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-09-17T10:29:14.803000-04:00 | ||
| 1437324 | MARSHALL BRACHMAN a47e0983-f7fe-43f8-92a4-8f835703b840 | Q3 | MARSHALL BRACHMAN | 6848 | BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM | 2013 | third_quarter | MED | support funding for medical research programs | HOUSE OF REPRESENTATIVES,SENATE | 33000 | 0 | 0 | 2013-10-01T00:05:02.943000-04:00 | |
| 1437438 | HARRISON RIVARD DUNCAN & BUZZETT, CHTD. 1049d728-2540-4b8d-b1dc-4c91a3f68539 | Q3 | HARRISON RIVARD DUNCAN & BUZZETT, CHTD. | 72257 | HCA HEALTHCARE | 2013 | third_quarter | MED | Health and Medical Issues | 0 | 0 | 2013-10-01T12:18:53.873000-04:00 | |||
| 1437777 | THE PETRIZZO GROUP, INC. 55daa09c-5161-43e5-88e2-bc63c37759b7 | Q3 | THE PETRIZZO GROUP, INC. | 305932 | ALLEN INSTITUTE | 2013 | third_quarter | MED | Participated and advocated for the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative. Support for full funding of NIH | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 20000 | 0 | 0 | 2013-10-02T19:15:40.693000-04:00 | |
| 1437778 | THE PETRIZZO GROUP, INC. ec7f601f-3819-44c9-ba5b-29e408a90c9c | Q3 | THE PETRIZZO GROUP, INC. | 305932 | FRED HUTCHINSON CANCER RESEARCH CENTER | 2013 | third_quarter | MED | Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI) for FY 2014 Funding. Advocated for collaboration between the federal government and the Institute for Cancer Outcomes Research and Evaluation to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-10-02T19:17:41.690000-04:00 | |
| 1437833 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) ecb29a32-0b8d-4e1c-84f4-44c19f921175 | Q3 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | 400361684 | VIJUK EQUIPMENT, INC. | 2013 | third_quarter | MED | All matters dealing with pharmaceutical labeling | Food & Drug Administration (FDA) | 25000 | 0 | 0 | 2013-10-03T10:39:20.723000-04:00 | |
| 1437837 | PALMETTO GROUP 516e1af0-9e22-499e-9002-389b63e62538 | Q3 | PALMETTO GROUP | 18570 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2013 | third_quarter | MED | Federal Funding of AIDS vaccine Department of State, Foreign Operations, and Related Programs Appropriations Act, 2014 | SENATE | 22500 | 0 | 0 | 2013-10-03T11:05:24.630000-04:00 | |
| 1437911 | FEDERAL SOLUTIONS, LLC fa4d5e4b-87ae-4ef3-8a46-18aff5af9d86 | Q3 | FEDERAL SOLUTIONS, LLC | 311371 | JACKSONVILLE STATE UNIVERSITY | 2013 | third_quarter | MED | Labor/HHS/Education Appropriations Bill 2013: Provisions relating to disease research, education, and development | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-10-03T13:47:10.590000-04:00 | |
| 1437931 | FEDERAL SOLUTIONS, LLC 081b91b7-5650-430f-8e00-046b54f6bd96 | Q3 | FEDERAL SOLUTIONS, LLC | 311371 | MISSISSIPPI STATE UNIVERSITY | 2013 | third_quarter | MED | Labor/HHS/Education Appropriations Bill 2013: Provisions relating to disease research | Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 50000 | 0 | 0 | 2013-10-03T13:52:15.867000-04:00 | |
| 1437965 | GRIZZLE COMPANY 27bdcad6-1171-4650-aafe-38b52e3dde99 | Q3 | GRIZZLE COMPANY | 16987 | UNIVERSITY OF LOUISVILLE | 2013 | third_quarter | MED | Support for PICORI grant application. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2013-10-03T14:37:32.067000-04:00 | |
| 1438061 | AMERICAN COLLEGE OF CLINICAL PHARMACY 6ed427b5-52d2-46cd-89ad-983cceb8d0a0 | Q3 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2013 | third_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 111725 | 0 | 0 | 2013-10-04T09:57:27.077000-04:00 | |
| 1438222 | THE PETRIZZO GROUP, INC. 5b70b2ff-25ea-4636-9285-f8658a604333 | Q3 | THE PETRIZZO GROUP, INC. | 305932 | VULCAN INC -- A PAUL G ALLEN COMPANY | 2013 | third_quarter | MED | Participated and advocated for the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative. | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2013-10-06T09:39:32.187000-04:00 | |
| 1438231 | THE PETRIZZO GROUP, INC. d320c9c8-4f09-4998-b6d1-f37625b916cc | Q3 | THE PETRIZZO GROUP, INC. | 305932 | OMEROS CORPORATION | 2013 | third_quarter | MED | Advocate for federal funding for reaserch on traumatic brain injury, PTSD, and treatment of bleeding during surgery and trauma. | Defense, Dept of (DOD) | 30000 | 0 | 0 | 2013-10-06T10:18:35.297000-04:00 | |
| 1438962 | ROCK & ASSOCIATES 2401e3b7-3900-4465-8fbe-d8506eacb1e6 | Q3 | ROCK & ASSOCIATES | 33545 | BRAIDWOOD MANAGEMENT, INC. | 2013 | third_quarter | MED | S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. | HOUSE OF REPRESENTATIVES,SENATE | 11200 | 0 | 0 | 2013-10-08T15:05:41.507000-04:00 | |
| 1438997 | ROCK & ASSOCIATES 407d1250-c99d-4a09-9f06-d1b3569776b2 | Q3 | ROCK & ASSOCIATES | 33545 | CAPITOL HILL CONSULTING GROUP (ON BEHALF OF WELLNESS PHARMACY) | 2013 | third_quarter | MED | S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-10-08T16:17:03.940000-04:00 | ||
| 1439022 | ROCK & ASSOCIATES 2efc8e48-038e-47f8-9779-fedb2371ef54 | Q3 | ROCK & ASSOCIATES | 33545 | DIAMONDBACK DRUGS | 2013 | third_quarter | MED | S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. | HOUSE OF REPRESENTATIVES,SENATE | 11200 | 0 | 0 | 2013-10-08T16:25:12.103000-04:00 | |
| 1439033 | ROCK & ASSOCIATES 9128610a-95d7-427a-87ab-8fde1303fb55 | Q3 | ROCK & ASSOCIATES | 33545 | VETERINARY PHARMACIES OF AMERICA, INC. | 2013 | third_quarter | MED | S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. | HOUSE OF REPRESENTATIVES,SENATE | 11200 | 0 | 0 | 2013-10-08T16:37:20.167000-04:00 | |
| 1439054 | ROCK & ASSOCIATES b6a474f2-50c7-40de-b5aa-797e3d39a188 | Q3 | ROCK & ASSOCIATES | 33545 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2013 | third_quarter | MED | S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. | HOUSE OF REPRESENTATIVES,SENATE | 11200 | 0 | 0 | 2013-10-08T16:47:28.187000-04:00 | |
| 1439066 | ROCK & ASSOCIATES 77b91e60-fecc-4557-b3a9-32df69be9c13 | Q3 | ROCK & ASSOCIATES | 33545 | WOMEN'S INTERNATIONAL PHARMACY | 2013 | third_quarter | MED | S.959, H.R. 3089 & H.R. 3204, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. | HOUSE OF REPRESENTATIVES,SENATE | 11200 | 0 | 0 | 2013-10-08T16:56:37.737000-04:00 | |
| 1439257 | ASSN OF MEDICAL DEVICE REPROCESSORS 65eff704-7209-498d-adb9-90042d4cec2d | Q3 | ASSN OF MEDICAL DEVICE REPROCESSORS | 291732 | ASSN OF MEDICAL DEVICE REPROCESSORS | 2013 | third_quarter | MED | Educated Congressional staff, members of Congress, and other agency officials on the FDA-regulated, third-party reprocessing industry and ongoing efforts to implement similar regulations internationally. Contacted VA and House and Senate about regulations for reprocessed single-use medical devices. | HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 0 | 0 | 2013-10-09T10:36:23.560000-04:00 | ||
| 1439394 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b5e58c43-41f1-488b-bb6f-ad49aff7858d | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | STATE UNIVERSITY SYSTEM OF FLORIDA | 2013 | third_quarter | MED | Appropriations and Authorization legislation for FY 2014 in health care HR 2397 Department of Defense Appropriations Bill 2014 and Senate bill HR 2216 Military Construction and Veterans Affairs Appropriations Bill FY2014 and Senate bill | Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE | 70000 | 0 | 0 | 2013-10-09T12:49:35.297000-04:00 | |
| 1439658 | MCDERMOTT WILL & SCHULTE LLP 7d5efd10-88c0-4ff2-9c7f-68d2de6f3d3e | Q3 | MCDERMOTT WILL & SCHULTE LLP | 24338 | COALITION FOR 21ST CENTURY MEDICINE | 2013 | third_quarter | MED | Issues concerning regulation of laboratory tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2013-10-09T15:36:46.300000-04:00 | |
| 1439677 | MCDERMOTT WILL & SCHULTE LLP 5b8532e7-619c-44e1-935f-c37447d79c84 | Q3 | MCDERMOTT WILL & SCHULTE LLP | 24338 | GENOMIC HEALTH INC | 2013 | third_quarter | MED | FDA regulation of laboratory-developed tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-10-09T15:42:54.403000-04:00 | ||
| 1439943 | AMERICAN SOCIETY FOR MICROBIOLOGY ba9e9e3b-43be-4542-b513-5693d8b21aca | Q3 | AMERICAN SOCIETY FOR MICROBIOLOGY | 3355 | AMERICAN SOCIETY FOR MICROBIOLOGY | 2013 | third_quarter | MED | Laboratory Test Reimbursement | Centers For Medicare and Medicaid Services (CMS) | 0 | 0 | 2013-10-10T10:13:21.720000-04:00 | ||
| 1439989 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 73532052-e8ed-4857-87e5-3ddf54c14af8 | Q3 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2013 | third_quarter | MED | * AACC joined with other laboratory groups in writing to the HHS OIG raising concerns regarding the findings of a June 2013 OIG report on laboratory reimbursement. * AACC joined with other laboratory groups in writing to CMS in opposition to proposed cuts in pathology reimbursement rates outlined in the July 19, 2010 Physician Feee Schedule Proposed Rule for CY 2014. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),SENATE | 0 | 0 | 2013-10-10T11:14:44.303000-04:00 | ||
| 1440001 | LNE GROUP a8eb516c-8095-4d77-9ca9-10b7eb01e952 | Q3 | LNE GROUP | 308811 | GOJO INDUSTRIES | 2013 | third_quarter | MED | Lobbied on issues regarding medical industry | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-10-10T11:15:49.617000-04:00 | ||
| 1440048 | LNE GROUP 4ca310bf-f382-41d8-9d19-5ef161391873 | Q3 | LNE GROUP | 308811 | ZIMMER | 2013 | third_quarter | MED | Lobbied for medical device issues. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-10-10T11:29:08.210000-04:00 | |
| 1440065 | RUBICON ADVISORS, LLC e73068e4-4714-4f9c-bd6e-001cae3f3d83 | Q3 | RUBICON ADVISORS, LLC | 315091 | COLLEGE OF AMERICAN PATHOLOGISTS | 2013 | third_quarter | MED | Physician Payment rates, Electronic Health Records Incentives Program | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-10-10T11:39:13.637000-04:00 | |
| 1440107 | COVINGTON & BURLING LLP d21d5593-f175-43bc-bf5a-9cf7aa8f1961 | Q3 | COVINGTON & BURLING LLP | 11195 | AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA) | 2013 | third_quarter | MED | FDA proposal to regulate clinical laboratory testing. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-10-10T12:48:42.867000-04:00 | |
| 1440615 | LNE GROUP d1f205c0-a221-4dff-993c-424c18d99fcf | Q3 | LNE GROUP | 308811 | INTRINSIQ MATERIALS | 2013 | third_quarter | MED | Lobbied for issues regarding the medical research | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-10-11T09:52:23.303000-04:00 | |
| 1440704 | LNE GROUP ca3996fc-5149-42e0-af79-5ee00c16c240 | Q3 | LNE GROUP | 308811 | PARKER HANNIFIN | 2013 | third_quarter | MED | Lobbied on issues regarding the medical field/disease research/clinical labs | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2013-10-11T11:04:19.600000-04:00 | |
| 1441107 | PARRY, ROMANI, DECONCINI & SYMMS c349c190-9624-4f4c-b560-79e784787cc2 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | AIDS HEALTHCARE FOUNDATION | 2013 | third_quarter | MED | Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014. Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-10-11T14:38:28.513000-04:00 | |
| 1441210 | CALIFORNIA LIFE SCIENCES a231f537-cf21-43af-a2e7-a4f56ac12c4a | Q3 | CALIFORNIA LIFE SCIENCES | 7758 | CALIFORNIA LIFE SCIENCES | 2013 | third_quarter | MED | Support NIH research funding. | HOUSE OF REPRESENTATIVES,SENATE | 160000 | 0 | 0 | 2013-10-11T15:39:28.097000-04:00 | |
| 1441282 | PARRY, ROMANI, DECONCINI & SYMMS ef6c3927-4d9e-4d59-86a6-3aa4ac640635 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) | 2013 | third_quarter | MED | Support H.R. 2985, the Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-10-11T16:36:10.343000-04:00 | |
| 1441392 | CHARLIE MCBRIDE ASSOCIATES 0311dba2-42e8-44c8-bc03-151b496616e8 | Q3 | CHARLIE MCBRIDE ASSOCIATES | 24214 | BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA | 2013 | third_quarter | MED | To monitor legislation affecting medical energy research and technology-based economic development | HOUSE OF REPRESENTATIVES,SENATE | 7200 | 0 | 0 | 2013-10-11T17:57:15.280000-04:00 | |
| 1441469 | BEN BARNES GROUP LP a91c4b8f-2735-4b0a-b4ed-64fac0854d96 | Q3 | BEN BARNES GROUP LP | 5415 | HUNTSMAN CANCER INSTITUTE | 2013 | third_quarter | MED | Cancer research | SENATE | 75000 | 0 | 0 | 2013-10-12T14:15:58.537000-04:00 | |
| 1441507 | BEN BARNES GROUP LP 39e218e3-50ed-4dfa-ba85-16dec6bb1ab5 | Q3 | BEN BARNES GROUP LP | 5415 | ROYALTY PHARMA - / RP MANAGEMENT, LLC | 2013 | third_quarter | MED | Tax Reform, Master Limited Partnership | HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2013-10-12T15:42:24.920000-04:00 | |
| 1441519 | BEN BARNES GROUP LP 54a6caf2-3e87-4738-9631-d3782b6e0735 | Q3 | BEN BARNES GROUP LP | 5415 | TEXAS A&M SYSTEM | 2013 | third_quarter | MED | Assist the Texas A&M System in pursuit of various projects, general government relations | HOUSE OF REPRESENTATIVES,SENATE | 25000 | 0 | 0 | 2013-10-12T16:09:34.093000-04:00 | |
| 1441593 | RAY C CULVER III 4990bbd6-3b3c-4835-b792-101a624c561a | Q3 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2013 | third_quarter | MED | Funding for the USDA ARS human nutrition centers in the FY14 Agricultural Appropriations bills, HR 2410 and S 1244. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-10-13T23:46:00.303000-04:00 | |
| 1441600 | SRI INTERNATIONAL bd8deaf4-61b7-4baf-b089-61a40c560d84 | Q3 | SRI INTERNATIONAL | 90990 | SRI INTERNATIONAL | 2013 | third_quarter | MED | House and Senate FY14 Labor/HHS/Education Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2013-10-14T08:39:09.867000-04:00 | |
| 1441659 | DANIELLE ORGAN PETERS 6181a8ee-1591-4bb8-bd9b-2b3bcd7b9edd | Q3 | DANIELLE ORGAN PETERS | 400427062 | CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP | 2013 | third_quarter | MED | Public policy to incentivize antibiotic drug development and innovation | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-10-14T10:14:44.090000-04:00 | ||
| 1441704 | THE CJR GROUP, INC. 2d3bdb75-3a73-4fde-ad38-16c459a308e4 | Q3 | THE CJR GROUP, INC. | 288293 | UNIVERSITY HOSPITALS HEALTH SYSTEM | 2013 | third_quarter | MED | Medical issues relating to hospitals | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-10-14T10:58:07.857000-04:00 | |
| 1441774 | HOLLAND & KNIGHT LLP cc1d22b7-85a5-4acd-adf7-cec3c2361a7c | Q3 | HOLLAND & KNIGHT LLP | 18466 | PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION | 2013 | third_quarter | MED | Over the counter drug approval process for sunscreen ingredients; H.R. 2410, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2013-10-14T11:56:47.723000-04:00 | |
| 1441985 | WAKE FOREST UNIVERSITY HEALTH SCIENCES 5199b1e5-bada-4e54-ad06-c703a59f34a0 | Q3 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 6781 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2013 | third_quarter | MED | NIH Budget including Title VII & VIII programs-Sequestration-C.R. Debt Ceiling Negotiations | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 145000 | 0 | 0 | 2013-10-14T15:35:24.480000-04:00 | |
| 1442413 | HOLLAND & HART LLP 506a6e7e-966b-47f5-925c-4da48f25a09c | Q3 | HOLLAND & HART LLP | 18444 | TOURO UNIVERSITY | 2013 | third_quarter | MED | Monitor legislation affecting Graduate Medical Education; H.R. 1201-Training Tomorrows Doctors Today Act; | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-10-15T10:27:06.113000-04:00 | |
| 1442556 | GOLDBUG STRATEGIES LLC 89c75220-1894-4fdf-bc81-d65d75383bbf | Q3 | GOLDBUG STRATEGIES LLC | 400701094 | COALITION FOR 21ST CENTURY MEDICINE | 2013 | third_quarter | MED | FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-10-15T11:38:16.050000-04:00 | |
| 1442560 | ROCK & ASSOCIATES b85f9265-d81d-4734-880d-b35817d2897e | Q3 | ROCK & ASSOCIATES | 33545 | US COMPOUNDING | 2013 | third_quarter | MED | S.959, H.R. 3089 & H.R. 3204 legislation affecting the operation of compounding pharmacies and the availability of compounded medications. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-10-15T11:41:18.690000-04:00 | ||
| 1442583 | GOLDBUG STRATEGIES LLC 07ad00ef-4048-4275-9e53-6f50abfc643a | Q3 | GOLDBUG STRATEGIES LLC | 400701094 | GENOMIC HEALTH INC. | 2013 | third_quarter | MED | FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-10-15T11:45:28.473000-04:00 | |
| 1442601 | GOLDBUG STRATEGIES LLC 4c74e4a4-775c-4ff1-953e-71bad529cbc7 | Q3 | GOLDBUG STRATEGIES LLC | 400701094 | LIFE TECHNOLOGIES/THERMO FISHER | 2013 | third_quarter | MED | regulation of medical devices, in vitro diagnostics and laboratory developed tests | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-10-15T11:55:37.770000-04:00 | ||
| 1442780 | TURNER & GOSS LLP 9b52ea86-7bc8-4635-aa8b-84fe1787b56e | Q3 | TURNER & GOSS LLP | 316310 | CYSTIC FIBROSIS FOUNDATION | 2013 | third_quarter | MED | Proposals related to Food and Drug Administration standards for accelerated approval of new products | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-10-15T13:48:19.597000-04:00 | ||
| 1442968 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 71657f8e-81e6-4fab-a01a-6a3614f60efa | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | TUBEROUS SCLEROSIS ALLIANCE | 2013 | third_quarter | MED | No HR #/S. 1284, Labor-HHS-Education Appropriations Bill, FY 2014, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention HR 2397/ S 1429, Defense Appropriations, FY 2014 Defense health programs, Tuberous Sclerosis Complex Research Program | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-10-15T15:22:43.737000-04:00 | |
| 1443057 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. bdafac9a-fdfc-4a1a-bbaa-55e03724f9a9 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN SOCIETY OF HEMATOLOGY | 2013 | third_quarter | MED | Research in hematology | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 40000 | 0 | 0 | 2013-10-15T15:49:16.440000-04:00 | |
| 1443082 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 609c813e-19ba-4b4f-b421-67fedd99518d | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL HEMOPHILIA FOUNDATION | 2013 | third_quarter | MED | Hemophilia research, prevention, surveillance and service programs and issues. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE | 50000 | 0 | 0 | 2013-10-15T15:55:30.330000-04:00 | |
| 1443098 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 90066502-dc56-4fdb-a88a-79e5273adaf0 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL ASSOCIATION OF EPILEPSY CENTERS | 2013 | third_quarter | MED | Research and public health programs in epilepsy. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2013-10-15T15:58:41.567000-04:00 | |
| 1443167 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. aa121ae6-fe11-486b-b756-aafb248788d9 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ASSOCIATION OF AMERICA'S BLOOD BANKS | 2013 | third_quarter | MED | Blood safety and management issues. HHS Advisory Committee on Blood Safety and Availability. Research related to Biovigilance. | Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-10-15T16:12:02.877000-04:00 | |
| 1443173 | WEBMD HEALTH CORP. f68ac219-49a2-4374-9acc-9002d7dbd64a | Q3 | WEBMD HEALTH CORP. | 55473 | WEBMD HEALTH CORP | 2013 | third_quarter | MED | Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers. Federal health care reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and deduction of expenses associated with advertising; Personal health records | SENATE | 30000 | 0 | 0 | 2013-10-15T16:13:04.660000-04:00 | |
| 1443231 | THOMPSON HINE LLP d635ac6c-5b66-4173-947f-c118d27bff34 | Q3 | THOMPSON HINE LLP | 38051 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 2013 | third_quarter | MED | Legislative and regulatory matters regarding the use of chimpanzees in biomedical research (i.e., the Great Ape Protection and Cost Savings Act and possible "endangered species" designation for chimpanzees by the U.S. Fish and Wildlife Service). | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2013-10-15T16:34:32.113000-04:00 | |
| 1443566 | UNIVERSITY OF IOWA 889ca90c-f37f-416c-bc87-65c3f45d68c2 | Q3 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2013 | third_quarter | MED | FY 2012 Appropriations Residency Caps Minority Improvement NIOSH Education and Research Centers for Occupational Health and SafetyPrevention Research Centers Resident Physician Shortage Health Care Reform FY 2013 Appropriations FY 2014 Appropriations | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT) | 85562 | 0 | 0 | 2013-10-16T10:02:14.043000-04:00 | |
| 1443691 | POLICY DIRECTIONS INC. a4cd75e2-f4f8-4e68-865b-30f57a6eecdb | Q3 | POLICY DIRECTIONS INC. | 31747 | CHARLES RIVER LABORATORIES | 2013 | third_quarter | MED | Pre-clinical research models and drug discovery, development and testing. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-10-16T10:39:15.747000-04:00 | |
| 1443806 | THE CONAFAY GROUP, LLC 056638a8-b0dc-439f-a9e3-b7be1236488e | Q3 | THE CONAFAY GROUP, LLC | 401004840 | CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP | 2013 | third_quarter | MED | Improving the enviroment for antibiotic drug development | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2013-10-16T11:08:09.340000-04:00 | |
| 1443944 | K&L GATES, LLP fef2241a-df4b-44b5-bceb-0012ab250e80 | Q3 | K&L GATES, LLP | 32098 | SMITS SPEIDELL CONSULTING | 2013 | third_quarter | MED | Yet to be introduced: A bill to amend the Internal Revenue Code of 1986 to broaden the special rules for certain governmental plans under section 105(j) to include plans established by political subdivisions. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-10-16T11:47:22.760000-04:00 | |
| 1444084 | PRIME POLICY GROUP 1e4eb96e-180c-4906-be93-82f31d02a5ac | Q3 | PRIME POLICY GROUP | 400532589 | GLAXOSMITHKLINE | 2013 | third_quarter | MED | Medicare Part D | HOUSE OF REPRESENTATIVES | 40000 | 0 | 0 | 2013-10-16T12:37:41.807000-04:00 | |
| 1444136 | PERSONALIZED MEDICINE COALITION 04ff1975-3e7d-42c4-9359-a0835a19f1c8 | Q3 | PERSONALIZED MEDICINE COALITION | 40046362 | PERSONALIZED MEDICINE COALITION | 2013 | third_quarter | MED | Personalized medicine regulation, CMS coverage of personalized medicine diagnostics, CER and Genomics, FDA regulation of personalized medicine | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2013-10-16T13:07:04.273000-04:00 | |
| 1444317 | THE OUTLAW GROUP e19a659d-37b5-4f1c-bd25-0c568a24d0f1 | Q3 | THE OUTLAW GROUP | 46095 | AMERICAN TINNITUS ASSOCIATION | 2013 | third_quarter | MED | Legislation to promote enhanced research into tinnitus by the National Institutes of Health and ohter general legislation of interest to tinnitus researchers and patients. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-10-16T14:23:37.927000-04:00 | |
| 1444324 | SQUIRE PATTON BOGGS cc685908-b9c4-420a-ba88-1142cbe1b3ef | Q3 | SQUIRE PATTON BOGGS | 30906 | SST, SHOTSPOTTER, INC. | 2013 | third_quarter | MED | Issues related to health as a result of illegal gun violence. | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Security Council (NSC),SENATE | 60000 | 0 | 0 | 2013-10-16T14:26:42.273000-04:00 | |
| 1444425 | THEODOSIOU CONSULTANTS 57434c5c-5b66-49a6-bb07-e0633fb0a7b3 | Q3 | THEODOSIOU CONSULTANTS | 54621 | THEODOSIOU CONSULTANTS | 2013 | third_quarter | MED | Medical Device Excise Tax, Clinical Trials Cancer Research | Administration for Children & Families (ACF),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-10-16T14:56:01.180000-04:00 | ||
| 1444461 | THEODOSIOU CONSULTANTS a6ba4539-6e04-46f0-9320-1a26f9cc5974 | Q3 | THEODOSIOU CONSULTANTS | 54621 | VIATRONIX INCORPORATED | 2013 | third_quarter | MED | Reimbursement | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-10-16T15:10:09.820000-04:00 | ||
| 1444515 | INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS de706dfd-1115-42a0-937a-604b3b0784d9 | Q3 | INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS | 19822 | INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS | 2013 | third_quarter | MED | The IBEW along with the AFL-CIO lobbied congress against changing the Medicare eligibility age and means testing of the Medicare program. | Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE | 247461 | 0 | 0 | 2013-10-16T15:21:10.727000-04:00 | |
| 1444761 | FORBES-TATE fbb11de9-31b4-4b5c-8ee7-80c02400b4c0 | Q3 | FORBES-TATE | 400976792 | AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION | 2013 | third_quarter | MED | Issues related to Medicare and Medicaid payments to physicians; issues related to medical imaging; issues related to Sustained Growth Rate (SGR). | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2013-10-16T16:16:36.630000-04:00 | |
| 1444832 | INTERNATIONAL MYELOMA FOUNDATION ebb7a49a-b2f0-48c4-87b3-f0d5a7cd7410 | Q3 | INTERNATIONAL MYELOMA FOUNDATION | 400595820 | INTERNATIONAL MYELOMA FOUNDATION | 2013 | third_quarter | MED | HR 1801, Cancer Drug Coverage Parity Act | HOUSE OF REPRESENTATIVES,SENATE | 54000 | 0 | 0 | 2013-10-16T16:38:05.723000-04:00 | |
| 1444923 | WILLIAMS MULLEN eb917ee4-e167-41d5-a483-604c72b613d9 | Q3 | WILLIAMS MULLEN | 47201 | OWENS & MINOR | 2013 | third_quarter | MED | Issues related to medical supplies | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2013-10-16T17:10:53.163000-04:00 | ||
| 1444935 | BRACEWELL LLP 60f5e68a-88ca-4aae-b17d-76620114e076 | Q3 | BRACEWELL LLP | 6837 | AIR LIQUIDE USA LLC | 2013 | third_quarter | MED | Work related to medical gases | Bureau of Land Management (BLM),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),Internal Revenue Service (IRS),SENATE,Treasury, Dept of | 60000 | 0 | 0 | 2013-10-16T17:20:00.943000-04:00 | |
| 1445062 | STANFORD UNIVERSITY 8e0b593a-5983-46e9-a7d0-34790a8421c6 | Q3 | STANFORD UNIVERSITY | 36492 | STANFORD UNIVERSITY | 2013 | third_quarter | MED | Health Professional Programs Graduate Medical Education Funding | Defense, Dept of (DOD),Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE | 80000 | 0 | 0 | 2013-10-16T17:49:15.787000-04:00 | |
| 1445324 | VAN SCOYOC ASSOCIATES 0c7a6e4f-6d8e-4d31-a3a4-e807ad03b600 | Q3 | VAN SCOYOC ASSOCIATES | 39837 | FLORIDA INTERNATIONAL UNIVERSITY | 2013 | third_quarter | MED | Medical research and Community Health Center related issues and initiatives. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-10-17T05:27:11.587000-04:00 | |
| 1445355 | VAN SCOYOC ASSOCIATES 36f0b1ba-d098-410d-b073-548e817f8504 | Q3 | VAN SCOYOC ASSOCIATES | 39837 | MEDICAL UNIVERSITY HOSPITAL AUTHORITY | 2013 | third_quarter | MED | Medical research and development related issues. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2013-10-17T06:03:27.300000-04:00 | |
| 1445652 | MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) e0c21477-4340-439f-b186-7707bb7a84fe | Q3 | MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) | 400265214 | MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) | 2013 | third_quarter | MED | Issues related to Federally sponsored research including NIH and DoD | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 249964 | 0 | 0 | 2013-10-17T09:32:42.567000-04:00 | |
| 1445683 | PARALYZED VETERANS OF AMERICA ce6db379-9ec5-4cf2-ba35-17217dc5f0ef | Q3 | PARALYZED VETERANS OF AMERICA | 30724 | PARALYZED VETERANS OF AMERICA | 2013 | third_quarter | MED | Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues | HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA) | 85456 | 0 | 0 | 2013-10-17T09:40:51.117000-04:00 | |
| 1445790 | THEODOSIOU CONSULTANTS f05e97bb-47cb-4278-96b8-790e410004b2 | 3A | THEODOSIOU CONSULTANTS | 54621 | VIATRONIX INCORPORATED | 2013 | third_quarter | MED | Reimbursement | HOUSE OF REPRESENTATIVES,SENATE | 36899 | 0 | 0 | 2013-10-17T10:11:42.680000-04:00 | |
| 1445792 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 13f7b4f2-8982-4b27-b35f-314bbee5e080 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2013 | third_quarter | MED | Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act; HR 1309: Health Information Technology Reform Act HR 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013 | Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE | 30000 | 0 | 0 | 2013-10-17T10:12:37.400000-04:00 | |
| 1445813 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 72ddcd80-c2a4-4ebf-834f-f9fddb5159ca | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ONYX PHARMACEUTICALS | 2013 | third_quarter | MED | Innovation in biotechnology; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases, health disparities, drug shortages. Public Law No: 112-144 Food and Drug Administration Safety and Innovation Act | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2013-10-17T10:16:47.290000-04:00 | |
| 1445821 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e27dac4b-fd37-411a-8cc6-6ddeb9080b82 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | INTERNATIONAL MYELOMA FOUNDATION | 2013 | third_quarter | MED | Cancer Drug Coverage Parity Act, H.R. 1801 | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-10-17T10:19:51.710000-04:00 | |
| 1445976 | NATIONAL ASSOCIATION OF SPINE SPECIALISTS b1b93fe8-adf8-4fd5-9ff0-fda766042ddb | Q3 | NATIONAL ASSOCIATION OF SPINE SPECIALISTS | 400395865 | NATIONAL ASSOCIATION OF SPINE SPECIALISTS | 2013 | third_quarter | MED | Spinal Cord Injury Funding. | HOUSE OF REPRESENTATIVES,SENATE | 42867 | 0 | 0 | 2013-10-17T10:54:54.210000-04:00 | |
| 1446227 | FAEGRE DRINKER BIDDLE & REATH LLP 352417d7-f1ce-4169-a334-a0715b589226 | Q3 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | ALLIANCE FOR BIOSECURITY | 2013 | third_quarter | MED | BioShield Project; Biomedical Countermeasures; Biodefense Research and Development Authority; Pandemic and All-Hazards Preparedness Reauthorization (H.R. 2405 and S. 1855) | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 50000 | 0 | 0 | 2013-10-17T11:32:42.410000-04:00 | |
| 1446294 | PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE f26bd9db-0b8b-4e90-8eda-24c2982ef219 | Q3 | PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE | 400382759 | PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE | 2013 | third_quarter | MED | Preservation of Antibiotics for Medical Treatment Act--H.R. 1150 | HOUSE OF REPRESENTATIVES,SENATE | 20777 | 0 | 0 | 2013-10-17T11:48:09.473000-04:00 | |
| 1446359 | TOWNSEND PUBLIC AFFAIRS, INC 931440d9-7a35-4e7a-aca4-76b4fa6bda0c | Q3 | TOWNSEND PUBLIC AFFAIRS, INC | 54734 | CITY OF SAN PABLO | 2013 | third_quarter | MED | Health/Childhood Obesity | Economic Development Administration,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE | 15000 | 0 | 0 | 2013-10-17T12:02:34.507000-04:00 | |
| 1446651 | MEHLMAN CONSULTING, INC. 49758ec9-3d7c-4049-9e6d-91a40a9710ae | Q3 | MEHLMAN CONSULTING, INC. | 284950 | MAYO CLINIC | 2013 | third_quarter | MED | NIH appropriations Clinical laboratory reimbursement | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2013-10-17T12:51:31.990000-04:00 | |
| 1446756 | THORN RUN PARTNERS 36ff8f53-5db7-46f9-b3f6-30a6da0c5bdd | Q3 | THORN RUN PARTNERS | 400534596 | ABBOTT LABORATORIES | 2013 | third_quarter | MED | Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. | HOUSE OF REPRESENTATIVES | 40000 | 0 | 0 | 2013-10-17T13:11:10.990000-04:00 | |
| 1446913 | THORN RUN PARTNERS 927ccb04-f196-41be-8fce-e54942220dcf | Q3 | THORN RUN PARTNERS | 400534596 | CHILDRENS HOSPITAL COLORADO | 2013 | third_quarter | MED | Issues related to clinical research. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-10-17T13:48:19.257000-04:00 | |
| 1446979 | UNIVERSITY OF KENTUCKY 3a38898a-bb52-4339-bf6a-199d7b1fd245 | Q3 | UNIVERSITY OF KENTUCKY | 400287372 | UNIVERSITY OF KENTUCKY | 2013 | third_quarter | MED | FY14 funding for NIH, HRSA, CDC, NIOSH | HOUSE OF REPRESENTATIVES,SENATE | 57000 | 0 | 0 | 2013-10-17T14:01:50.083000-04:00 | |
| 1447022 | IKARIA 9689b3d4-628e-4d79-b067-f50d9ba95480 | Q3 | IKARIA | 400758262 | IKARIA | 2013 | third_quarter | MED | Funding for rare disease research | HOUSE OF REPRESENTATIVES,SENATE | 130000 | 0 | 0 | 2013-10-17T14:10:09.773000-04:00 | |
| 1447472 | THORN RUN PARTNERS 98ccb0fb-f68e-4015-810e-3284f5b5a6bb | Q3 | THORN RUN PARTNERS | 400534596 | NOVARTIS CORPORATION | 2013 | third_quarter | MED | Issues related to biologics. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-10-17T14:59:43.880000-04:00 | |
| 1447530 | PRIME POLICY GROUP a9e4161d-5712-4bff-b4e1-10281841c46f | Q3 | PRIME POLICY GROUP | 400532589 | VERAX BIOMEDICAL, INC. | 2013 | third_quarter | MED | Blood Safety | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-10-17T15:05:11.193000-04:00 | |
| 1447785 | THE LIVINGSTON GROUP, LLC bf41954a-0f0b-42c2-b423-400ac5f01f1c | Q3 | THE LIVINGSTON GROUP, LLC | 49635 | MAYO CLINIC | 2013 | third_quarter | MED | H.R._____, S.3295, FY 2013 Labor-Health and Human Services-Education appropriations bill, National Institutes of Health (NIH) funding; and executive pay scale for extramural NIH researchers. | Federal Railroad Administration,HOUSE OF REPRESENTATIVES,Natl Transportation Safety Board (NTSB),SENATE,Transportation, Dept of (DOT) | 50000 | 0 | 0 | 2013-10-17T15:32:10.317000-04:00 | |
| 1448040 | LIFE TECHNOLOGIES CORPORATION 1bd63e40-f477-4723-be0d-35b9df946328 | Q3 | LIFE TECHNOLOGIES CORPORATION | 400391833 | LIFE TECHNOLOGIES CORPORATION | 2013 | third_quarter | MED | H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only or Investigational Use Only:" Frequently Asked Questions; Provisions regarding regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2013-10-17T15:58:58.717000-04:00 | |
| 1448350 | BAKER BOTTS, L.L.P. 36a1babc-3e5b-456e-871c-5efaec40b2aa | Q3 | BAKER BOTTS, L.L.P. | 5118 | SOUTHERN METHODIST UNIVERSITY | 2013 | third_quarter | MED | Funding of neurophotonics research for prosthetic devices | Army, Dept of (Other),Defense Advanced Research Projects Agency (DARPA),HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2013-10-17T16:23:47.183000-04:00 | |
| 1448640 | THE CORMAC GROUP, LLC 737ba49d-c5d5-4023-87ef-c177ce90219d | Q3 | THE CORMAC GROUP, LLC | 66773 | KESSLER FOUNDATION | 2013 | third_quarter | MED | Appropriations, DOD, TBI research | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2013-10-17T17:11:07.323000-04:00 | |
| 1448647 | WINNING STRATEGIES WASHINGTON 1a88f492-567c-46e0-b451-bff1c81d43d4 | Q3 | WINNING STRATEGIES WASHINGTON | 50796 | LAHEY HEALTH | 2013 | third_quarter | MED | PPACA implementation; nursing education; rural wage index | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2013-10-17T17:11:09.777000-04:00 | |
| 1448745 | BRACEWELL LLP 8d713a6a-e70c-4e1b-84ec-4a0e8807139b | Q3 | BRACEWELL LLP | 6837 | NATIONAL BRAIN TUMOR SOCIETY | 2013 | third_quarter | MED | work related to the advancement of the Cancer Drug Coverage Parity Act of 2013 | HOUSE OF REPRESENTATIVES | 0 | 0 | 2013-10-17T17:29:51.230000-04:00 | ||
| 1448766 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 8372e6c2-53b0-4cfa-9a58-0881c366a35f | Q3 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) | 2970 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) | 2013 | third_quarter | MED | HR 1098 - Brain Injury Reauthorization Act of 2013: Support passage. S. 1027 - Rehabilitation Research Improvement Act: Advocate to improve coordination and enhance rehabilitation research at the National Institutes of Health. Support passage. | HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 110000 | 0 | 0 | 2013-10-17T17:33:58.807000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);